Potentially inappropriate medications and medication combinations before, during and after hospitalizations: an analysis of pathways and determinants in the Swiss healthcare setting

被引:1
作者
Migliazza, Kevin [1 ,2 ]
Bahler, Caroline [1 ]
Liedtke, Daniel [3 ]
Signorell, Andri [1 ]
Boes, Stefan [2 ]
Blozik, Eva [1 ,4 ]
机构
[1] Helsana Grp, Dept Hlth Sci, Zurich, Switzerland
[2] Univ Lucerne, Dept Hlth Sci & Med, Luzern, Switzerland
[3] Hirslanden Grp, Zurich, Switzerland
[4] Univ Zurich, Inst Primary Care, Zurich, Switzerland
关键词
Drug safety; Hospitalization; Healthcare transitions; Inappropriate medication; DDI; PIM; DRUG-DRUG INTERACTIONS; ELDERLY-PATIENTS; BLOCKCHAIN TECHNOLOGY; REGIONAL-VARIATION; CONTROLLED-TRIAL; AMBULATORY-CARE; CONSENSUS PANEL; OLDER-PEOPLE; PREVALENCE; POPULATION;
D O I
10.1186/s12913-021-06550-w
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BackgroundA hospitalization phase represents a challenge to medication safety especially for multimorbid patients as acute medical needs might interact with pre-existing medications or evoke adverse drug effects. This project aimed to examine the prevalence and risk factors of potentially inappropriate medications (PIMs) and medication combinations (PIMCs) in the context of hospitalizations.MethodsAnalyses are based on claims data of patients (>= 65years) with basic mandatory health insurance at the Helsana Group, and on data from the Hirslanden Swiss Hospital Group. We assessed PIMs and PIMCs of patients who were hospitalized in 2013 at three different time points (quarter prior, during, after hospitalization). PIMs were identified using the PRISCUS list, whereas PIMCs were derived from compendium.ch. Zero-inflated Poisson regression models were applied to determine risk factors of PIMs and PIMCs.ResultsThroughout the observation period, more than 80% of patients had at least one PIM, ranging from 49.7% in the pre-hospitalization, 53.6% in the hospitalization to 48.2% in the post-hospitalization period. PIMCs were found in 46.6% of patients prior to hospitalization, in 21.3% during hospitalization, and in 25.0% of patients after discharge. Additional medication prescriptions compared to the preceding period and increasing age were the main risk factors, whereas managed care was associated with a decrease in PIMs and PIMCs.ConclusionWe conclude that a patient's hospitalization offers the possibility to increase medication safety. Nevertheless, the prevalence of PIMs and PIMCs is relatively high in the study population. Therefore, our results indicate a need for interventions to increase medication safety in the Swiss healthcare setting.
引用
收藏
页数:18
相关论文
共 82 条
[31]   Drug-related problems in older people after hospital discharge and interventions to reduce them [J].
Garcia-Caballos, Marta ;
Ramos-Diaz, Francisco ;
Juan Jimenez-Moleon, Jose ;
Bueno-Cavanillas, Aurora .
AGE AND AGEING, 2010, 39 (04) :430-438
[32]   Drug-drug and drug-disease interactions in the ED: Analysis of a high-risk population [J].
Goldberg, RM ;
Mabee, J ;
Chan, L ;
Wong, S .
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 1996, 14 (05) :447-450
[33]   Effect of Continuity of Care on Drug-Drug Interactions [J].
Guo, Jiun-Yu ;
Chou, Yiing-Jenq ;
Pu, Christy .
MEDICAL CARE, 2017, 55 (08) :744-751
[34]   A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy [J].
Hanlon, JT ;
Weinberger, M ;
Samsa, GP ;
Schmader, KE ;
Uttech, KM ;
Lewis, IK ;
Cowper, PA ;
Landsman, PB ;
Cohen, HJ ;
Feussner, JR .
AMERICAN JOURNAL OF MEDICINE, 1996, 100 (04) :428-437
[35]   Factors associated with suboptimal analgesic use in community-dwelling elderly [J].
Hanlon, JT ;
Fillenbaum, GG ;
Studenski, SA ;
ZiqubuPage, T ;
Wall, WE .
ANNALS OF PHARMACOTHERAPY, 1996, 30 (7-8) :739-744
[36]   Potentially Inappropriate Medications in the Elderly: The PRISCUS List [J].
Holt, Stefanie ;
Schmiedl, Sven ;
Thuermann, Petra A. .
DEUTSCHES ARZTEBLATT INTERNATIONAL, 2010, 107 (31-32) :543-U39
[37]  
Institute for Healthcare Improvement, MEDICATION RECONCILI
[38]  
Janko G., 2009, DETERMINANTS CONSUME, P238
[39]   Analysis of Drug-Drug Interactions in Swiss Claims Data Using Tizanidine and Ciprofloxacin as a Prototypical Contraindicated Combination [J].
Jodicke, Annika M. ;
Curkovic, Ivanka ;
Zellweger, Urs ;
Tomka, Ivan T. ;
Neuer, Thomas ;
Kullak-Ublick, Gerd A. ;
Roos, Malgorzata ;
Egbring, Marco .
ANNALS OF PHARMACOTHERAPY, 2018, 52 (10) :983-991
[40]   Prediction of health care expenditure increase: how does pharmacotherapy contribute? [J].
Joedicke, Annika M. ;
Zellweger, Urs ;
Tomka, Ivan T. ;
Neuer, Thomas ;
Curkovic, Ivanka ;
Roos, Malgorzata ;
Kullak-Ublick, Gerd A. ;
Sargsyan, Hayk ;
Egbring, Marco .
BMC HEALTH SERVICES RESEARCH, 2019, 19 (01)